Joe Driscoll is CEO and Co-Founder of Evol Science, which uses unique technology to identify new pathways of cancer cell resistance, and creates new combination therapies designed to attack the mechanisms of resistance and metastasis in melanoma, pancreatic and lung cancers. Joe has worked as an investment consultant and company manager, focused on investing in and growing small businesses. In 2006, Joe led the acquisition of Boston Ship Repair, a struggling company with 450 manufacturing jobs at risk, and working with all stakeholders built a business plan that doubled revenue, and tripled net income over 24 months. In 2004, Joe was the Democratic Candidate for Pennsylvania's 15th Congressional District. Joe received his BA from Harvard University, and an MBA from Harvard Business School.